Affiliations 

  • 1 Department of Ophthalmology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: [email protected]
  • 2 Department of Molecular Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: [email protected]
  • 3 KK Women's and Children's Hospital, Singapore. Electronic address: [email protected]
  • 4 Department of Ophthalmology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: [email protected]
  • 5 Department of Ophthalmology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: [email protected]
Exp Eye Res, 2021 10;211:108734.
PMID: 34428458 DOI: 10.1016/j.exer.2021.108734

Abstract

This study aimed to investigate the metabolite differences between patients with keratoconus and control subjects and identify potential serum biomarkers for keratoconus using a non-targeted metabolomics approach. Venous blood samples were obtained from patients with keratoconus (n = 20) as well as from age-, gender- and race-matched control subjects (n = 20). Metabolites extracted from serum were separated and analyzed by liquid chromatography/quadrupole time-of-flight mass spectrometer. Processing of raw data and analysis of the data files was performed using Agilent Mass Hunter Qualitative software. The identified metabolites were subjected to a principal component and hierarchical cluster analysis. Appropriate statistical tests were used to analyze the metabolomic profiling data. Together, the analysis revealed that the dehydroepiandrosterone sulfate from the steroidal hormone synthesis pathway was significantly upregulated in patients with keratoconus (p 

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.